Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia In Vitro Diagnostics Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering.
The Saudi Arabia in vitro diagnostics (IVD) market, valued at USD 1.42 Billion in 2024, is witnessing robust growth driven by rising chronic disease prevalence and technological advancements. Forecasted to grow at a CAGR of 5.40% from 2025 to 2034, the market is expected to reach USD 2.40 Billion by 2034. This growth is largely supported by Vision 2030 healthcare investments, molecular diagnostics, and point-of-care testing.
Market Overview
The Saudi Arabia IVD market is buoyed by increased healthcare spending and a rising demand for advanced diagnostic solutions. Government initiatives aimed at enhancing healthcare infrastructure and the adoption of modern technologies significantly contribute to market expansion. The Vision 2030 initiative, which prioritizes healthcare modernization and digital integration, plays a pivotal role in fostering innovation within the market. Strategic collaborations with global leaders such as Roche Diagnostics further accelerate market growth.
Growth Drivers and Trends
An increasing prevalence of chronic diseases such as diabetes, hypertension, obesity, and asthma serves as a key growth catalyst. In December 2023, a study reported high rates of these conditions, compounded by elevated body mass index levels across the populace, underscoring the demand for advanced diagnostic solutions. Additionally, the growing geriatric population amplifies the need for diagnostic testing. Between 2020 and 2022, individuals aged 60 and older comprised 5.59% to 6.9% of the population in Saudi Arabia, a trend contributing to heightened market demand.
Market Segmentation
The Saudi Arabia IVD market is segmented by product and services, technology, application, and end user. Products and services include reagents, kits, instruments, software, and services, while technologies encompass immunodiagnostics, molecular diagnostics, clinical chemistry, and more. Applications span infectious diseases, diabetes, oncology, and beyond, with major users being hospitals, diagnostic centers, and academic institutes.
Market Dynamics and Key Players
Infectious diseases are poised to drive market growth, fueled by high prevalence rates, such as hepatitis B and dengue fever. This necessitates rapid diagnostic solutions, positioning the infectious diseases segment as a significant growth driver.
Leading players in the market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Abbott, and Thermo Fisher Scientific Inc. Roche provides advanced diagnostic solutions, while Bio-Rad leads with its QXDx product line, offering precise DNA and RNA quantification. Abbott's high-throughput systems and Thermo Fisher's innovative devices enhance diagnostic capabilities, fostering operational efficiency in clinical settings. Other prominent players are QIAGEN, Quidel Corporation, and Danaher Corporation.
Conclusion
The Saudi Arabia in vitro diagnostics market is poised for substantial growth, driven by chronic disease prevalence, governmental investments in healthcare digitization, and strategic industry collaborations. As the demand for advanced diagnostic solutions continues to rise, the market is expected to expand further, offering numerous opportunities for industry leaders and new entrants alike.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2025-2034 |
| Estimated Market Value (USD) in 2025 | $1.42 Billion |
| Forecasted Market Value (USD) by 2034 | $2.4 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Saudi Arabia |
Companies Featured
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Abbott
- Thermo Fisher Scientific Inc.
Key Topics Covered
1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage - Key Segmentation and Scope
- 1.4 Research Methodology
2 Executive Summary
3 In Vitro Diagnostics Market Overview
- 3.1 Middle East and Africa In Vitro Diagnostics Market Overview
- 3.2 Saudi Arabia In Vitro Diagnostics Market Overview
4 Saudi Arabia In Vitro Diagnostics Market Landscape
- 4.1 Saudi Arabia In Vitro Diagnostics Market: Developers Landscape
- 4.2 Saudi Arabia In Vitro Diagnostics Market: Product Landscape
5 Saudi Arabia In Vitro Diagnostics Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 PESTEL Analysis
- 5.4 Porter's Five Forces Model
- 5.5 Key Demand Indicators
- 5.6 Key Price Indicators
- 5.7 Industry Events, Initiatives, and Trends
- 5.8 Value Chain Analysis
6 Saudi Arabia In Vitro Diagnostics Market Segmentation (2018-2034)
- 6.1 By Product & Services
- 6.2 By Technology
- 6.3 By Application
- 6.4 By End User
7 Regulatory Framework
8 Funding and Investment Analysis
9 Strategic Initiatives
10 Supplier Landscape
11 Saudi Arabia In Vitro Diagnostics Market - Distribution Model (Additional Insight)
12 Key Opinion Leaders (KOL) Insights (Additional Insight)
For more information about this report visit https://www.researchandmarkets.com/r/xg8k65
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
